Skip navigation

Catalog

Online
Added:09/02/2026 14:46

SNMMI TLOG Webinar Series: Theranostics Tumor Board - Challenging Cases of Lu 177 Therapy (July 2026)
Credits awarded per Session. See individual Sessions for further details.
Credits awarded
Type
Name
Sub type
Value
Certificate awarded
Already successfully completed: This item allows re-enrollment

About this item

SNMMI TLOG Webinar Series: Theranostics Tumor Board - Challenging Cases of Lu 177 Therapy (July 2026)

Course/Activity Information

SNMMI TLOG Webinar Series: Theranostics Tumor Board - Challenging Cases of Lu 177 Therapy (July 2026)

Sponsored by SNMMI Theranostics Leadership and Operations Group (TLOG)
 

Technologist Member Fee: Free; Non-Member Fee: $32.00
Physician Member Fee: Free; Non-Member Fee: $49.00
Physicist Member Fee: Free; Non-Member Fee: $40.00
Pharmacist Member Fee: Free; Non-Member Fee: $40.00
Non-Credit Member Fee: Free; Non-Member Fee: $40.00

Release Date: July 27, 2026           Expiration Date: July 31, 2029
(Please note that the activity content will not be accessible after the expiration date.)


Presenter(s)

Aamna Hassan, MD, ABNM, CCD, Senior Consultant and Nuclear Medicine Physician
Hajira Ilyas, MRCP MSc FRCR, Consultant in Radiology and Nuclear Medicine
Sana Munir Gill, MBBS, FCPS, Consultant Physician
Sadaf Mufty, FCPS, Consultant Physician
Shaukat Khanum Memorial Cancer Hospital and Research Center


Organizer(s)

Aamna Hassan, MD, ABNM, CCD, Senior Consultant and Nuclear Medicine Physician

Moderator(s)
Aamna Hassan, MD, ABNM, CCD, Senior Consultant and Nuclear Medicine Physician

 

 

Name Role Disclosure
Aamna Hassan, MD, ABNM, CCD Organizer/ Moderator/ Presenter Senior Consultant and Nuclear Medicine Physician, Shaukat Khanum Memorial Cancer Hospital and Research Center
Nothing to disclose
Hajira Ilyas, MRCP MSc FRCR Presenter Consultant in Radiology and Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Center
Nothing to disclose
Sana Munir Gill, MBBS, FCPS Presenter Consultant Physician, Shaukat Khanum Memorial Cancer Hospital and Research Center
Nothing to disclose
Sadaf Mufty, FCPS Presenter Consultant Physician, Shaukat Khanum Memorial Cancer Hospital and Research Center
Nothing to disclose
The Theranostics Leadership and Operations Group, reviewers and SNMMI Staff have indicated that they do not have a financial interest arrangement or affiliation with any commercial organization that may have a direct or indirect interest in the content presented.
Gholam Reza Berenji, MD, FACNM, FSNMMI Theranostics Leadership and Operations Group Chairperson
Attending Physician, Department of Veterans Affairs/UCLA
Novartis, AstraZeneca, Curium, Clarity, Blue Earth, Canon-Researcher
Delphine L. Chen, MD Theranostics Leadership and Operations Group Vice Chairperson
Professor, Wil B. Nelp Endowed Professorship in Nuclear Medicine-University of Washington
Trevarx, Telix Pharmaceuticals, GE Healthcare, Astra Zeneca, Novartis, United Imaging-Researcher; Washington University in St. Louis (patent holder)
Arnold M. Strashun, MD

CE Reviewer & Chair, Continuing Education Committee

Professor, Vice Chairman and Program Director of Radiology
University Hospital of Brooklyn

Nothing to disclose

Lisa Dickinson

SNMMI Staff - Director of Education

Nothing to disclose

No Commercial Support was received for this activity.

Any relevant financial relationships listed for these individuals have been mitigated.

 

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education and the SNMMI Conflict-of-Interest Policy, the speaker, moderator, organizers, planners, reviewers and staff have indicated no relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.

Target Audience
Nuclear medicine physicians, technologists, physicists, and pharmacists.

Objectives
At the completion of this activity the participant will be able to:
1. Discuss selection criteria of patients for Lu177 therapy
2. Identify possible side effects of Lu177 therapy
3. Discuss pros and cons of re-challenge therapy

Continuing Education Credit Information
To receive CE credit, learners must first complete the activity content, achieve a score of 80% on the post-course assessment, and complete the evaluation.  Learners will have no more than 3 attempts to successfully complete the post-test. This activity must be completed by the expiration date listed above. 

 

Physician (AMA PRA Category 1 CreditsTM):
The Society of Nuclear Medicine and Molecular Imaging Inc., (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

SNMMI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicists
This activity offers 1.0 AMA PRA Category 1 CreditTM for physicists who complete the assessment and evaluation. 


Pharmacist (ACPE):
The Society for Nuclear Medicine and Molecular Imaging Inc. (SNMMI) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been designated as knowledge-based CPE. Total available credit for pharmacists is 1.0 hours or 0.1 CEUs.


Technologist (VOICE):
The SNMMI, through its Verification of Involvement in Continuing Education (VOICE) program, has approved this meeting for a maximum of 1.0 continuing education hours (CEHs). VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT as Category A+ credit.  California Scope: 1.0 T-Therapy.


Minimum system requirements

Desktop
Mac OS 11, 12, 13
WBT makes every effort to test and support the most recent & stable versions of these web browsers: Apple Safari Version 11.x +; Google Chrome; Mozilla FireFox
Windows 10, 11
WBT makes every effort to test and support the most recent & stable versions of these web browsers: MS Edge; Google Chrome; Mozilla FireFox


Tablet/Smart Phone
iOS 12.x +
WBT makes every effort to test and support the most recent & stable version on the latest version of iOS: Safari, Google Chrome
Android 9+
WBT makes every effort to test and support the most recent & stable version on Android: Google Chrome, Native Android Browser, Mozilla FireFox

Recommendations and Requirements for All Browsers
- Enable Java, JavaScript, Cookies.
- Disable Pop-up Blockers
- The recommended minimum screen resolution on desktop is 1280 x 1024.
- The recommended minimum screen width resolution on iOS is 375px.
- The recommended minimum screen width resolution on Android is 400px.
- WBT Systems does not support beta versions of (supported) browsers.
- Plug-ins: Adobe Acrobat Reader (http://get.adobe.com/reader/) 

Hardware Requirements:
- Computer: 1 GHz with 500 MB RAM or better
- Internet Connection: A broadband connection (DSL Cable etc.)
- Sound: Speakers or headset to hear audio
- Display: A display screen area of 800 x 600 pixels or higher

For questions please contact the Education Department at [email protected]
© 2025 SNMMI. All rights reserved.    Policy on Privacy and Confidentiality

Other information

Additional Charges May Apply